Parkinson's UK was celebrating an "exciting year for research" at the second ever World Parkinson Congress in Glasgow.
The charity looked back on a year where it funded £4.5 million of new research, launched a five-year research strategy and hosted its second conference for UK Parkinson's researchers in York.
New research trials uncovered exciting new developments, looking at the possible role of metal pollution and genetic factors.
In addition, advances paving the way for new treatments involving cell transplants and new types of drugs.
Over 3,000 people attended the conference, coming together in Glasgow from 66 countries to share their experiences in the field.
Dr Kieran Breen, director of research and development, said that 2010 has been an encouraging year for Parkinson's research.
"We'll continue to fund groundbreaking research that improves life for people with Parkinson's and works towards our ultimate goal, a cure."
This comes after a study, published in Nature Neuroscience, said that scientists had isolated proteins in the brain that could lead to treatments for approximately 130 neurodegenerative and psychiatric illnesses.